FOR IMMEDIATE RELEASE
February 2, 2016
|CONTACT: James F. Jorkasky
AEVR ANNOUNCES MARCH 2016 CONGRESSIONAL BRIEFINGS
ON GLAUCOMA AND DEFENSE-RELATED VISION RESEARCH
(Washington, D.C.) Today, the Alliance for Eye and Vision Research’s (AEVR) Decade of Vision 2010-2020 Initiative announced Congressional Briefings to be held in March 2016 that support the vision community’s request for increased Fiscal Year (FY) 2017 appropriations for the National Eye Institute (NEI) and the Peer Reviewed Vision Research Program (VRP) in Department of Defense (DOD) appropriations. RSVP for both events to Dina Beaumont at 202-530-4672 or firstname.lastname@example.org.
Wednesday, March 9, 2016
World Glaucoma Week 2016 Congressional Briefing: Public Health Challenges in Glaucoma
12 Noon – 1:15 pm House Rayburn B-338
Featured speaker David S. Friedman, M.D., Ph.D., M.P.H. (Wilmer Eye Institute/Johns Hopkins University), a world renowned glaucoma specialist and clinician-scientist who has made a significant contribution to the study of the mechanisms, epidemiology, and prevention of angle-closure glaucoma, will address public health challenges presented by this eye disease—the second-leading cause of preventable vision loss in the United States.
Held to recognize World Glaucoma Week 2016, the event is co-sponsored by Research to Prevent Blindness, the American Glaucoma Society, the Association for Research in Vision and Ophthalmology, Glaucoma Research Foundation, Optometric Glaucoma Society, and The Glaucoma Foundation.
Thursday, March 17, 2016
Deployment-Related Vision Trauma Research: Development of a Drug-Delivering Contact Lens
12 Noon – 1:15 pm House Rayburn B-340
Featured speaker Joseph Ciolino, M.D. (Massachusetts Eye and Ear/Harvard Medical School), who is funded through multiple DOD awards, will discuss his research into the development of a corticosteroid-releasing Therapeutic Contact Lens (TCL) to treat ocular injuries and blinding eye diseases. This research, funded by a FY2014 Translational Research Award from the DOD’s Vision Research Program (VRP), addresses a DOD-identified research gap in “minimally-invasive drug delivery.”
The event is co-sponsored by Research to Prevent Blindness, the Association for Research in Vision and Ophthalmology, and Blinded Veterans Association.
Alliance for Eye and Vision Research (AEVR), a 501(c)3 non-profit foundation, is proud to announce these educational programs associated with its Decade of Vision 2010-2020 Initiative, a sustained educational effort acknowledged by Congress that recognizes the benefits of federally funded vision research. Visit its Web site at www.eyeresearch.org